Vascular Malformations_Somatic

Gene: HRAS

Green List (high evidence)

HRAS (HRas proto-oncogene, GTPase)
EnsemblGeneIds (GRCh38): ENSG00000174775
EnsemblGeneIds (GRCh37): ENSG00000174775
OMIM: 190020, Gene2Phenotype
HRAS is in 24 panels

1 review

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

Comment on list classification: Somatic activating mutations cause vascular malformations.
Created: 20 Jan 2020, 10:39 p.m. | Last Modified: 1 Jul 2020, 11:31 p.m.
Panel Version: 0.9
Somatic activating mutations in this gene cause vascular malformations. Germline variants cause the RASopathy, Costello syndrome.
Sources: Expert list
Created: 20 Jan 2020, 10:38 p.m.

Mode of inheritance
Other

Phenotypes
Extracranial arteriovenous malformations; Vascular malformation/overgrowth syndromes

Publications

Mode of pathogenicity
Other

History Filter Activity

1 Jul 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: hras has been classified as Green List (High Evidence).

1 Jul 2020, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag somatic tag was added to gene: HRAS.

1 Jul 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set mode of pathogenicity

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: HRAS was added gene: HRAS was added to Vascular Malformations_Somatic. Sources: Expert list,Expert Review Green Mode of inheritance for gene: HRAS was set to Other Publications for gene: HRAS were set to 31160609; 31637524; 30208313 Phenotypes for gene: HRAS were set to Vascular malformation/overgrowth syndromes; Extracranial arteriovenous malformations Mode of pathogenicity for gene: HRAS was set to Other